It is interesting to me that whilst the top 20 has not changed (some sold some some bought some evening it out), there isn't more buying from the top 20 for half price shares compared with cap raise.
- Forums
- ASX - By Stock
- IXC
- Ann: Appendix 4E and Annual Report
IXC
invex therapeutics ltd
Add to My Watchlist
0.00%
!
9.1¢

Ann: Appendix 4E and Annual Report, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.839M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 41290 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 41290 | 0.088 |
1 | 42086 | 0.083 |
1 | 40000 | 0.075 |
1 | 14285 | 0.070 |
1 | 16666 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 9000 | 1 |
0.099 | 59180 | 2 |
0.105 | 50000 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online